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Five 6-alkyl (n-tridecyl-, n-pentadecyl-, n-heptadecyl-, n-pentadecenyl- and n-heptadecenyl-) sali-
cylates Ia-e, in free and conjugated (esters, phospholipids) forms, constituting one of the largest
classes of bioactive metabolites have been isolated from the leaves and fruits of ten Ginkgo bi/oba
trees of different ages (3-80 years) and indigenous occurrence. These compounds have been charac-
terized by comprehensive chromatographic-spectroscopic analyses (HPTLC, HPLC, GC-MS, IH
NMR), chemical transformation, and by direct comparison of some of them with authentic markers.
Selective anti-oxidative (lipoxygenase modulatory), free radical captodative (DOH,DSOj), and anti-all-
ergic and anti-inflammatory screening of the total 1Gb extract and of Ia-e have been conducted. Our
findings suggest a significant contribution of the 6-alkylsalicylates towards the elixir effect of Ginkgo,
contrary to an earlier apprehension that ginkgolic acids (equivalent to 6-alkylsalicylates) might cause
allergic manifestations in recipients and, therefore, that they should be removed from Ginkgo for-
mulations.
Herbalists fondly refer to Ginkgo biloba Linn. as
the "living fossil"; being the oldest living plant
species with a 200 million-year history. It is the
sole survivor of the family Ginkgoaceae'. Ginkgo
was mentioned in the ancient Chinese pharmaco-
poeia for its many therapeutic uses", Formulations
of Ginkgo have, however, been introduced com-
paratively recently into the list of Occidental
(Western) phytomedicinesv'. It is recommended in
conditions related to geriatric complaints, peri-
pheral. circulatory insufficiency, and cerebrovascu-
lar disorders. The market of Ginkgo formulations
in the Western countries had an estimated annual
turnover of about 500 million US dollars in
1992-1993, which is steadily increasingv'. But,
surprisingly, no effort seems to have been made
to explore the potential of Indian Ginkgo biloba
(1Gb) although a number of Ginkgo medicines
from the West find a lucrative Indian market.
We have collected G. biloba (1Gb) plant materi-
als from different parts of India and established
their identities pharmacognostically and chemical-
ly following established procedures (see Experi-
mental Section). Phenolic lipids constitute one of
the three major classes of secondary metabolites
of G. biloba Linn., the other two being terpenoi-
dal lac tones and flavonoids. However, the former
class of compounds was completely eliminated
from the Western Ginkgo phytomedicinesv", due
to the presumption that they cause allergic mani-
festations (of the urushiol-type) in recipients. We
did not subscribe to this idea. We believe so long
as the carboxyl group in 6-alkylsalicylates in in-
tact (free or in conjugated form) there would not
be any allergic reaction. Our findings reported
herein validate this postulate.
Results and Discussion
(i)Isolation and structural study. Green
leaves from ten G. biloba trees of widely ranging
age-groups (3 to 80 years) were collected from
different parts of India (during August-October,
for two consecutive years) and processed for 6-al-'
kylsalicylates (see Experimental). These phenolic
lipids are represented by the general structures
Ia-e (Figure 1).The identities of these compounds
were established by comprehensive chromatogra-
phic-spectroscopic analyses (HPTLC, HPLC, GC-
MS. IH NMR), chemical transformations (selec-
tive deacylation, methylester acetate formation
trimethylsilylation), and by direct comparison,
where possible, with authentic markers.
The acetylmethyl esters exhibited characteristic
proton resonances, in their 1H NMR spectra, at
bO.85-0.88 (t, - CH3), 1.25 (m, - CHz -),
1.55(m, Ar-CHz-CHz-), 1.95 (m,
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Figure I-Structure and common mass fragment ions of 6-alkylsalicylates from Gingko
- Cl!z - CH = ), 2.20(s, CHJ€Ot, -2:-76(t,
Ar - CH2 - ), 3.82(s, - C02CH3), 5.3(m,
-CH=CH-), 6.8-7.2 (m, Ar-H). In the EI
MS, aside from the respective molecular-ion peak,
characteristic common fragment-ion peaks ap-
peared at m/z corresponding to M-42( - CH2CO)
and M-74( -CH30H, -CH2CO). Additionally,
prominent fragment-ion peaks appeared at m/z
147 (2), 119 (2 -CO); and 91 (base peak arising
from the tropilium ion, characteristic of the alkyl-
aryl moiety) (Figure 1).
The relative abundances (by GC-M~, HPLC) of
the 6-alkylsalicylates were reasonably consistent
being in the ranges 15±5% (Ia), 7±3 (lb), 4±1
(Ic), 65 ± 12 (ld), and 9 ± 3 (Ie). They altogether
comprised about 5% of the total lipids. Moderate
concentrations of phospholipids (0.1-0.8% wet
wt.) were also ~isolated, the range depending on the
age of the tree. The lipids of immature fruits, on
the other hand, were dominated but more var-
iably upto 70 ± 20% by phenolic lipids, free and
conjugated.
Aside from the complex lipoidal entities, two
other major groups of compounds isolated from
the different parts of the Indian Ginkgo, were
flavonoids (free and glycosylated/conjugated)
(yield, 0.2-0.5%) and terpenoidal lactones (ginkgo-
lides and bilobalide, 0.002-0.08%). Some of the
flavonoid compounds were strikingly found en-
caged within the cavity of the ginkgolide lactones
(The significance of this aspect warrants further
investigation as the reports made so far have not
recorded this observation).
The o-alkylated phenolic acids of Ginkgo were
outrightly neglected earlier+" probably because of
their structural similarity to the C20-CZ4[ (C7 + C13)-
(C7 + C17)1 fatty acids. However, unlike those of
the long chain fatty acids (derived from poly-j3-
'ketide intermediates), the biosynthesis of the side
chain and of the salicylate ring of the 6-alkylsali-
cylates involve separate sequences, .building
blocks, subcellular sites and different levels of cell
activation in G. bilobal
(ii)Survlval mechanism in Ginkgo Several gen-
era of the family Ginkgoaceae occupied the
Earth's ground surface some 200 to 100 million
years ago 1. Fossil Ginkgos were also found in the
Indian sub-continent (we have access to one such
precious Ginkgo fossil from Rajasthan), America,
Australia and Europe. All the Ginkgo species,
however, became extinct with the passage of time
except G. biloba. What is the secret of its
longevity?
G.biloba efficiently slows down the biochemical
process of aging. It is able to reproduce from the
age of about 20 years and can continue to do so
more than 1000 years 1. Ginkgo smoothly fends
off several static and dynamic stresses (cosmic ra-
diation, relentless atmospheric oxidation, microb-
ial infestation, environmental pollution) and the
adult respiratory syndromes (ARDS), presumably
by employing its low and medium M, metabolites \
that are produced in increased quantities in stress
(e.g. pruning) situations. Oxygen free radicals are
strongly implicated in the process of biologic ag-
ing in all Jiving species's", Hence, in G. biloba, the
antioxidative/radical captodative effects are mani-
fested best. The flavonoid consituents of Ginkgo
even though were reported~·6.10 t~_ attenuate the
adverse manifestations of systemically generated
superoxide radical (02), however, neither they
nor the congeneric terpenoidal lactones exhibi-
ted 10 any antioxidative or radical captodative ef-
fect when dhallenged with the most damaging hy-
droxyl ( OH) or sulphur-containing radicals.
(iii) Activity studies. We have now tested the
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Table I-Effects of Ginkgo extract, metabolites and formulations on free radical induced polymerization of methyl methacrylate
Group' Inhibitor Induction Amount of (Polymer-type)
(mg) period polymer
(rnin)" (mg)











Rkn + MMA+ S03
Bvs + MMA+ SO;
a Mean of ten replications
b Period between completion of addition of reactants and onset of precipitation, 1Gb, Indian Ginkgo bi/oba extract; Ger, Gin-
kocer; Rkn, Rokan; Bvs, Bilovas; inf; infinite time > 300 min.
20 (inf.> 300) 22±5 (PMMA ..•IGb)·
20 (inf. > 300) 38±7 (PMMA- l a-e)
40 30 602±24 (PMMA-Gcr)
40 32 552 ± 28 (PMMA-Rkn)
40 28 588 ± 34 (PMMA-Bvs)
15 782 ± 14 (PMMA-S03
20 150 112±8 (PMMA-IGb-S03 )
20 122 94±6 (PMMA-la-e-SO; )
40 25 690±24 (PMMA-Gcr-S03 )
40 25 705 ±26 (PMMA-Rkn-SOi)
40 25 744±28 (PMMA"Bvs-S03 )
anti-hydroxyl and anti-sulphite anion radical
(·SO;) effects of the total leaf-extracts of 1Gb and
of the 6-alkylsalicylates (La-e) against polymeriza-
tion of methyl methacrylate (MMA)l1. Both these
agents significantly protected MMA from polym-
erization by hydroxyl or sulphito-anion radicals. In
contrast, some of the commercial Ginkgo products,
e.g. Ginkocer, Bilovas and Rokan, prepared from
a patented formulation (EGb-761)5,6, were found
to be totally ineffective in this parameter (Table I).
The molecular participation of 1a-e in the polym-
erization reaction was suggested from the dielec-
tric properties (Table IT) of the products (high dis-
sipation factors of the PMMA polymers). The
small amount of the polymers (PMMA) produced,
with much shorter chain length than that of the
control (without the inhibitors), also sug-
gested that the phenolic ligands were incorporat-
ed into the PMMA polymers. This phenomenon
had precedent in the MMA protecting effects of
shilajit!' and of mangiferin'? under similar condi-
tions.
The beneficient effects of 1Gb and Ia-e asso-
ciated with their anti-free radical properties were
reflected in the pharmacological and immunologi-
cal profiles of these agents. Literature reports+?
suggested that no biological screening data are
available for the phenolic lipids of Ginkgo. In the
present study, the effects of 1Gb and Ia-e as anti-
inflammatory and anti-allergic agents and on the
biosynthesis of eicosanoids in Ca-ionophore acti-
vated human polymorphonuclear leukocytes
(PMNL) were evaluated.
1Gb (50 mg/kg, i.p.) and the 6-alkylsalicylates
(La-e, 50 mg/kg, i.p.) markedly attenuated carrage-
Table II-Dielectric properties of polymethyl methacrylates
with or without inhibitors'





















a Dielectric properties were measured at frequency, 1 MHz;
temp.20°e.
b Mean of ten replicates (see Experimental Section).
enan-induced pedal oedema in albino rats at 3
and 4 hr. The anti-inflammatory effect of these
agents was not manifested at the initial stages (1
and 2 hr) of the inflammation, mdicating that the
effect is mediated by certain other effector mole-
cules whose identityties) is not known at present.
However, when 1Gb (50 ug/ml,., and the 6-alkyl-
salicylates (50 ug) were administered intracere-
broventricularly (i.c.v.) into the rats, there was sign-
ificant inhibition of the pedal oedema throughout
the 4hr period of observation.
Delayed-type hypersensitive reactions in the an-
imal skin are often produced b'v foreign materials,
e.g. dinitrofluorobenzene (DNFB I and picryl chlo-
ride, which arc; capable of binding to body consti-
tuents to form antigens. Contact dermatitis can
occur in humans and in animals who become sen-
sitive to such chemicals (potenrial antigens). 1Gb
(as 2% cream) and ()-alkylsalicylates (0.2Cl/r. cream)
appreciably inhibited (30 ± 5%) the DNFB-in-
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duced contact dermatitis in rat ear. These Ginkgo
agents did not produce any allergic manifestation
per se. The 6-alkylsalicylates produced a biphasic
(dose-dependent) response on the biosynthesis of
the leukotrienes (LTB~ and w - OH - LTB4) and
the hydroxy-eicosatetraenoic acids (5-HETE and
12-HETE) suggesting its immuno-modulator (bio-
logical reponse modifier, BRM) effect on the li-
poxygenase pathway(s).
It seems appropriate now to correlate, at the
molecular level, the contributions of the phenolic
lipids to the producer organism. Oxygen uptake
by the effector proteins (oxygenases) of G. biloba
is probably accompanied by a concomitant re-
lease of anionic ligands (heterotrophic), e.g. the
phenolic lipids The phenolic lipids in turn may
reduce the heat released upon oxygen binding of
the proteins (cf. dielectric properties, Table II)
and thereby contribute to lower the overall en-
thalpy change ot the oxygenation reaction, a key
factor in the longevity of biological species. The
abundant presence and the production of these
anti oxidative and Iadical captodative agents, e.g.,
the phenolic lipids, would seem to counter the ef-
fects of oxidative stress to which G. biloba is re-
lentlessly exposed.
Conclusion
Attention has been drawn, in this communica-
tion, to the rewarding aspects of chemical and
biological evaluation of Ginkgo biloba Linn., oc-
curring in India. The 6-alkylsalicylates, occurring
in free and conjugated forms in all parts of Ginkgo
have been shown as yet another major class of its
bioactive agents. The significance of these phenol-
ic lipids (general structure, Ia-e, Figure 1) in the
health and longevity of G.biloba and, hence, in
the organisms ingesting Ginkgo is highlighted.
Anti-oxidative, free radical (·OH, ·S03- )captodative
anti-inflammatory and anti-allergic effects of the
total extracts of G. biloba leaves of Indian origin
(1Gb) and of the 6-alkylsalicylates are reported.
Herein we dispel the western equivocal notion
that the phenolic lipids (equivalent to ginkgolic
acids) might cause allergic manifestations in reci-
pients and should be removed from the Ginkgo
formulation, e.g. EGb 761. The present study has
demonstrated, for the first time that the carboxy
group containing 6-alkylsalicylates contributes po-
sitively towards the elixir effect of G.biloba.
Experimental Section
Plant materials-Leaves and fruits were peri-
odically collected, for two consecutive years, from
ten G. bi/oba trees of different age groups (3-5,
10-15, 20-30 and 60-80 years old), located at
Dehra Dun, Saharanpur, Manali and Ooty. The
findings reported here pertain to the collection
during August to October. The herbarium speci-
mens are preserved in the library of Prof. S. Gho-
sal.
The following techniques were applied for the
isolation and characterization of the chemical
constituents of 1Gb.
Column chromatography. Adsorbant: silicic ac-
id (Mallinck drodt, - 100 mesh), solvents of
graded polarity, e.g., n-hexane, hexane-diethyl
ether and ether were used as eluants.
HPTLC-CAMAG TLC evaluation assembly
(CATS 3.16/Scanner II V 3.14) applying both
flouresence and quenching modes of detection
was used; n-hexane-ether-acetic acid (80:19:1) was
used as the developer.
GC-MS. Hitachi M-4100 instrument; OV-1
(30M x 0.33 mm), operated with graded increase
in temperature from 80° to 280°C; ionization vol-
tage 20 eY.
HPLC-Waters assembly; RP-8 reverse phase
colunmequipp-ed with a PDA detector: (i) me-
thanol-water-acetic acid (80:20:0.2) I(ii) acetoni-
trile, as developers.
For comparison purposes, reference markers of
anacardic acids (An 15:0 and An 15:1 as major
entities) were employed in the HP1LC and HPLC
analyses.
NMR-Instrument, Varion XL-100; solvent,
CDCI3. Chemical shifts (b, ppm) were measured
relative to tetramethylsilane (TMS) as internal
standard.
Dielectric measurement-The dielectric propert-
ies of polymethyl methacrylates were measured
using a Hewlett-Packard impedence analyzer, op-
erating at 1 KHz to 1 MHz; the temperature was
maintained at 20°e. The relaxation effects ob-
served at 1 MHz are given in the Table n. The
general method of isolation of the phenolic lipids
is depicted in Scheme 1.
Separation of 6-alkylsalicylates by column
chromatography. The esters of fatty acids and the
conjugated 6-alkylsalicylates were separated by
column chromatography of the ether extract over
silicic acid. The column was sequentially eluted
with n-hexane (100%), hexane-diethyl ether
(99.5:0.5, 99:1, 95:5, 90:10, 50:50) and ether
(100). The eluants were combined according to
TLC-HPTLC analyses of the aliquots. The hexane
(100) and hexane-ether (99.5:0.5) eluates afforded
a mixture of fatty esters and less polar phospho-
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Green leaves of 1Gb (ca 109)
macerated in a Waring blender;
MeOH-H20 (40:60)(100 mL);
mixture warmed on a steam bath for 30 min.; filtered
Filtrate
I methanol removed under reduced pressure.
Aqueous concentrate
I lyophilized
Light brown powder (1.8- 2.5 g)
I extracted with peroxide free diethyl ether
Ether Extract
divided into two parts
Part I
Subjected to biological testing
Part II
I
Mixture of methyl esters of long chain fatty acids, phospholipids & 6-alkylsalicylates
I diluted with water;extracted with ether
Ether extractJ column chromat.
mixtures of methyl esters of
fatty acids & phospholipids
treated with absolute methanol, containing 3%.H2S04;




Scheme I-Isolatlon of phenolic lipids
lipids. The remaining eluates gave the 6-alkylsali-
cylates.
6-Alkylsalicylate-phospholipid conjugates. The
combined n-hexane and hexane-ether (99.5:0.5)
eluates was evaporated and the residue processed
for phospholipids according to previously de-
scribed procedures 13,14. Briefly, the residue was
extracted with pentane followed by aqueous
methanol (20:80). The residue from the latter ex-
tract contained the phospholipid conjugates (38
mg).
The mixture of triglycerides, polyunsaturated
fatty acids (PUFA), phenolic phospholipids (con-
taining 6-alkylsalicylaies at the C2-position of gly-
cerol moiety), and free 6-alkylsalicylates, obtained
from the aqueous methanol extract of the leaves
of G. biloba (1Gb), were separated by column
chromatography over silicic acid using eluants of
graded polarity. The eluates were combined ac-
cording to their TLC-HPTLC patterns. The 0-
acetylmethyl esters of 6-alkylsalicylates (La-e)
were prepared by acetylation (AC20-CsHsN) fol-
lowed by methylation (Et20-CH2N2). These deriv-
atives were separated by column chromatgraphy
and also by semi-preparative reverse phase HPLC
using methanol-water-acetic acid as developer.
Deacylation of the phospholipids (22 mg) was
carried out by treatment with a solution of anhy-
drous methanol-sodium methoxide (0.2 N, 0.5
mL) at room temperature for 1 hr. The solvent
was removed and the residue extracted with pen-
tane. The pentane-soluable fraction contained me-
thyl esters of the fatty acids including PUFA. The
pentane-insoluble residue was processed for
phenolic entities in the usual way and the product
extracted with ether. The residue from the ether
extract was acetylated by treatment with acetic
anhydride (0.5 mL) and pyridine (002 mL) at
room temperature overnight. The acetate deriva-
tive, in chloroform, was passed through a short
column of silica gel-H. Elution was carried out
with pet. ether (40-60°C) and petrol-chloroform
(99:1). The combined petrol-chloroform eluates
on GC-MS analyses showed appropriate mass
spectral patterns (Figure 1).
In another set, selective C2-deacylation of the
phospholipids was carried out by treating the resi-
due from hexane eluates (column chromatogra-
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phy) with phospholipase-A, (phosphatidyl- 2-acyl-
hydrolase, EC 3.1.1.4. Sigma Chemical Co.), at
pH 8.9; 25°C for 12 hr. The liberated 6-alkylsali-
cylic acids were taken in ether and analysed by
HPLC. The free o-alkylsalicylic acids from 1Gb
were isolated from the ether eluates of the co-
lumn in a similar way. Thus, 6-alkylsalicylic acids
were converted into O-acetylmethyl ester deriva-
tives by treatment with AC20-CsHsN followed by
methylation of the carboxyl group with ethereal
diazomethane. TLC of the product in hexane-
ether-acetic acid (74:25:1) showed acetylmethyl
esters at Rt 0.64; UV: A.max nm (log £):240 (3.42),
290~92 (3.88) (in MeOH). The free 6-alkylsalicyl-
ic acids and their methyl esters showed R, 0.45
and 0.35, respectively.
The O-acetylmethyl esters (general structure, Ia-
e) were subjected to 1H NMR spectroscopic anal-
ysis in CDCI3. The 6-alkylsalicylates of 1Gb were
characterized and quantified as their O-trimethyl-
silylmethyl ester derivatives, by GC-MS. Silylation
was done in pyridine with hexamethyldisilane-
trimethylchlorosilane (2:1) according to a pu-
blished procedure". The average composition of
the 6-alkylsalicylates in green leaves of 1Gb was,
alkyl 13:0 (18'Yo), 15:0 (2), 15:1 (65), 17:0 (5), 17:1
(10).
Polymerization of MMA by free radicals: Fen-
ton reagent induced polymerization. 1Gb (20 mg)
was dissolved in double distilled water (20 mL),
through which N 2 was passed for 30 min. Ferrous
sulphate (10 mg) and hydrogen peroxide (30%,
0.05 ml.) were added, sequentially MMA (940
mg) was then added and the reaction mixture kept
in a dark place, at ambient temperature
(20 ± 5°C). The periods of onset and completion
of polymerization were noted. The polymer
(PMMA-IGb) was collected by filtration. The
precipitate was repeatedly washed with water and
dried in vacuo. The product was further purified
by dissolving in benzene and re-precipitating with
methanol. The weight of the pure, dry precipitate
was noted (Table I). The polymerization of MMA
in the presence of 6-alkylsalicylates to ~ve
PMMA-la-e, and in the absence of anyone of
these inhibitors to give the control polymer
(PMMA-Fenton), were carried out in a similar
manner. Likewise, Ginkocer (PMMA-Gcr), Rokan
(PMMA-Rkn) and Bilovas (PMMA-Bvs) were em-
ployed as potential inhibitors. The results are in-
corporated in Table I.
Sulphito anion radical induced polymerization
of MMA. The SO) radical was generated by in-
teraction of potassium metabisulphite and ammo-
nium persulphate as before": The results of po-
lymerization in the presence and absence of the
above inhibitors are incrporated in Table I. .
.Pharmacologi<:al and immunological screening
of 1Gb and the 6-alkylsalicylates: (i) Anti-
inflammatory effect. 1Gb {50 mg/kg, i.p.) and Ia-e
(50 mg/kg, i.p.), in separate sets, were adminis-
tered to albino rats (120-150g), prior to pedal in-
flammation induced by carrageenan (0.1 ml of 1%
suspension in 0.9% saline )16.
(ii)Anti-aliergic effect. 2, 4-Dinitrofluoroben-
zene (DNFB) (0.5%), in ethyl alcohol-acetone
(4:1) solution was applied for sensitization of the
ear of albino rats (120-150g; b.w.). On the 5th
day, after sensitization, DNFB solution (0.2%)
was used for challenging and production of con-
tact dermatitis in the sensitized zones. The inflam-
mation produced with or without prior treatment
with 1Gb and Ia-e was measured after the chal-
lenge at 1 hr and 12 hourly interval. The extent
of inflammation was measured by the thickness of
the ear (oedema of the epidermis with microvesi-.
de formation) and the extent of allergy by the
redness of the ear. The results are incorporated in
the text.
Effects of 1Gb and Ia-e on the biosynthesis of
eicosanoids. 1Gb (50 ug/ml.) and 1 a-e (50 ug/
mL), in vitro were tested on the biosynthesis of
leukotrienes, viz. LTB and oi-hydroxy-Ll'B, and
5-hydroxyeicosatetraenoic acid (5-HETE) and 12-
hydroxyeicosatetraenoic acid (12-HETE), in hu-
man PMNL, following a published procedure'",
Human granulocytes were isolated by using dex-
tran sedimentation, hypnotic lysis of erythrocytes
and density gradient". The granulocyte prepara-
tion contained 85-90% neutrophils (viability
> 95% as determined by trypan blue exclusion
method). The identification of the eicosanoid pro-
ducts was done by HPLC (retention time, tR) us-
ing authentic markers (Cascade Biochemical Ltd.).
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